Survey on AI for melanoma diagnostics in children, adolescents and young adults

Invitation to participate in survey on AI for melanoma diagnostics in children, adolescents and young adults – German Cancer Research Center, Heidelberg

As part of the European Commission funded MELCAYA consortium, the Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ) is developing an artificial intelligence (AI)-based tool for the diagnosis of melanoma in children, adolescents and young adults. Within this project, surveys were designed to gain deeper insights into the perspectives, concerns and expectations of different stakeholders.

Please note that participants have the opportunity to be acknowledged as PubMed-indexed collaborators in any publications resulting from this study.

The DKFZ would like to invite you to participate in this survey. The survey will be filled out anonymously online and takes about 20 minutes. No prior knowledge is required.
You can access the survey specifically designed for dermatologists via the following link: fm.addxt.com/f/?t=tjBEsg
 
Information for participants who wish to be acknowledged as PubMed-indexed collaborators:

If you took part in the survey and wish to be acknowledged as PubMed-indexed collaborators in any publications resulting from this study please send an email to “david.krauss-roskamm@dkfz-heidelberg.de” mentioning so (if not already done). You will then get a confirmation email once we have put you on our list. Note, that this procedure is necessary to ensure anonymous survey responses.

If you have any questions please do not hesitate to contact us.
 
Yours sincerely,
David Krauss-Roskamm
Deutsches Krebsforschungszentrum
- Stiftung des öffentlichen Rechts
Im Neuenheimer Feld 280
69120 Heidelberg